Loading...
Loading...
India's trastuzumab imports from NEW ZEALAND total $1.5K across 1 shipments from 1 foreign suppliers. NZCR NEW ZEALAND CLINICAL RESEARCH leads with $1.5K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include CURATEQ BIOLOGICS PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for trastuzumab โ a concentrated sourcing relationship with select suppliers from NEW ZEALAND.

NZCR NEW ZEALAND CLINICAL RESEARCH is the leading Trastuzumab supplier from NEW ZEALAND to India, with import value of $1.5K across 1 shipments. The top 5 suppliers โ NZCR NEW ZEALAND CLINICAL RESEARCH โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NZCR NEW ZEALAND CLINICAL RESEARCH | $1.5K | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | CURATEQ BIOLOGICS PRIVATE LIMITED | $1.5K | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Trastuzumab suppliers from NEW ZEALAND to India include NZCR NEW ZEALAND CLINICAL RESEARCH. The leading supplier is NZCR NEW ZEALAND CLINICAL RESEARCH with import value of $1.5K USD across 1 shipments. India imported Trastuzumab worth $1.5K USD from NEW ZEALAND in total across 1 shipments.
India imported Trastuzumab worth $1.5K USD from NEW ZEALAND across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Trastuzumab sourced from NEW ZEALAND include CURATEQ BIOLOGICS PRIVATE LIMITED. The largest buyer is CURATEQ BIOLOGICS PRIVATE LIMITED with $1.5K in imports across 1 shipments.
The total value of Trastuzumab imports from NEW ZEALAND to India is $1.5K USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists